TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 310 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q2 2020. The put-call ratio across all filers is 1.16 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $214,000 | +13.2% | 14,995 | +30.2% | 0.02% | +21.1% |
| Q3 2021 | $189,000 | +3.3% | 11,515 | +6.2% | 0.02% | +5.6% |
| Q2 2021 | $183,000 | -6.6% | 10,844 | -4.7% | 0.02% | -21.7% |
| Q1 2021 | $196,000 | -0.5% | 11,375 | +2.3% | 0.02% | -4.2% |
| Q4 2020 | $197,000 | +5.9% | 11,116 | +4.8% | 0.02% | -45.5% |
| Q1 2020 | $186,000 | -12.3% | 10,607 | +0.5% | 0.04% | 0.0% |
| Q4 2019 | $212,000 | +1.0% | 10,557 | +0.4% | 0.04% | -4.3% |
| Q3 2019 | $210,000 | +14.1% | 10,510 | -2.1% | 0.05% | +7.0% |
| Q2 2019 | $184,000 | -13.6% | 10,737 | +1.6% | 0.04% | -23.2% |
| Q4 2018 | $213,000 | – | 10,563 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Adelphi Capital LLP | 9,270,535 | $188,841,000 | 39.13% |
| Sachem Head Capital | 5,963,600 | $121,479,000 | 7.38% |
| NINE MASTS CAPITAL Ltd | 1,049,886 | $21,415,000 | 6.68% |
| Paulson & Co. | 26,489,422 | $539,590,000 | 5.77% |
| Blackcrane Capital, LLC | 189,549 | $3,861,000 | 5.16% |
| Glenview Capital Management | 26,112,660 | $531,915,000 | 4.75% |
| Exane Asset Management | 430,369 | $8,766,617,000 | 4.26% |
| Velanne Asset Management Ltd | 281,972 | $5,744,000 | 3.97% |
| Bluefin Trading, LLC | 1,204,702 | $24,540,000 | 3.55% |
| Endurant Capital Management LP | 437,436 | $8,911,000 | 3.52% |